Trial
NCT05037500
Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Roswell Park Cancer Institute
Collaborators
National Comprehensive Cancer Network
Condition
Castration-Resistant Prostate Carcinoma
Intervention
Decitabine and Cedazuridine
Why stopped
PI closed study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-11-12